Transfer of innovation and knowledge: 3D Cell Culture Conference 2023
From 17th to 19th April, our CEO Martin Raasch and our scientists Anne-Katrin Bothe and Tim Kaden attended the 3D Cell Culture Conference in Freiburg. As in 2021, the conference was a great opportunity for Dynamic42 to exchange ideas with colleagues about 3D cell cultures and interesting model applications – this year, finally in presence again.
Almost 200 participants from 14 countries presented the latest trends, innovations and advances in the fields of developmental biology, organoids, microphysical models and personalised medicine. We not only received interesting impressions from our international colleagues, discussed new findings in research projects, but also presented our own research results.
DECHEMA: Gesellschaft für Chemische Technik und Biotechnologie e.V.
It was particularly noticeable that many companies or scientists have not yet tapped into our “organ-on-chip” field of activity. Thus, we were still downright exotic at the conference. However, the density of research groups and exhibitors with highly innovative equipment and new cell culture material also shows that there is a high interest in new approaches. We strongly believe that many from academia and industry will switch from 2D to 3D culture due to higher complexity and physiology. . In general, there was a high relevance of new possibilities for tumour therapies and personalised medicine. We are also making a significant contribution to this field of research with the development of a pancreatic cancer model (PDAC). With the organ-on-chip technology, we expect great progress in this field in the future.
Tim Kaden at 3D Cell Culture Conference
Contributions from Dynamic42 GmbH
On the second day of the conference, our scientist Tim Kaden presented his results on “Emulation of DSS-induced inflammatory bowel disease in a microphysiological intestine-on-chip to study the protective role of secondary bile acids” on the podium. Afterwards, our project partner from Heinrich-Heine-Universität Düsseldorf, Prof. Dr. Nicole Teusch, presented results from our joint research project “Patient-derived spheroid-on-a-chip model to identify novel personalized therapeutic approaches for pancreatic cancer”.
While Nicole and Tim presented on stage, our scientist Anne-Kathrin Bothe held a poster presentation on “Predicting immune-related antibody-induced toxicities with microphysiological organ-on-chip models”. At this point, we had even more opportunities for exchange, for new impressions and for expanding our network.
The 3DCC was again an enriching event with extensive scientific exchange. The highlight of the conference was an incredible gala dinner with an impressive view over the city and a multitude of impulses that we could take back to Jena. We also see ourselves clearly confirmed in the fact that there is enormous potential in organ-on-chip technology to model and investigate human-relevant diseases and to unravel potential therapeutic interventions strategies. We thank the organisers and all participants and we are looking forward to see you all in Freiburg again!
More interesting articles:
Learn the skills to integrate organ-on-chip technology into your lab work with the Dynamic42 Academy. If this resonates with you, this blog will help you to understand if our organ-on-chip class is for you. We will give you a deep dive into the reasons to attend our course, what we teach in the course, and what past participants have to say.Read More
A comprehensive summary of available organ-on-chip courses, detailing the provider, content and location. Organ-on-chip technology is an amazing technique to model human, physiological mechanisms on a small scale without the use of animal models. If you as a researcher are versed in cell culture, learning how to create your own organ models is absolutely feasible in just a few months.Read More
We look back on 2023 - from significant milestones, groundbreaking developments and trusting partnerships to new faces in our team. We'll take you with us as we review the past year.Read More